FDA approves ceftolozane/tazobactam (Zerbaxa); 4th new antibiotic in 2014
www.pulmccm.org
The U.S. FDA continued its flurry of new antibiotic approvals to close out 2014, giving the nod to ceftolozane with tazobactam. The drug will be marketed as Zerbaxa by the pharmaceutical company Cubist. Ceftolozane is a novel cephalosporin, combined with the existing β-lactamase inhibitor tazobactam in the new product. Zerbaxa has broad activity against gram-negative bacteria, including
FDA approves ceftolozane/tazobactam (Zerbaxa); 4th new antibiotic in 2014
FDA approves ceftolozane/tazobactam…
FDA approves ceftolozane/tazobactam (Zerbaxa); 4th new antibiotic in 2014
The U.S. FDA continued its flurry of new antibiotic approvals to close out 2014, giving the nod to ceftolozane with tazobactam. The drug will be marketed as Zerbaxa by the pharmaceutical company Cubist. Ceftolozane is a novel cephalosporin, combined with the existing β-lactamase inhibitor tazobactam in the new product. Zerbaxa has broad activity against gram-negative bacteria, including